Emergent BioSolutions
EBS
#8527
Rank
โ‚น24.06 B
Marketcap
โ‚น467.98
Share price
-1.94%
Change (1 day)
-46.65%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น473.86

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น467.06. In 2025 the company made an earnings per share (EPS) of โ‚น88.04 an increase over its 2024 EPS that were of -โ‚น336.39.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น473.86-638.26%
2025โ‚น88.04-126.17%
2024-โ‚น336.39-75.61%
2023-โ‚น1,379232.21%
2022-โ‚น415.16-203.46%
2021โ‚น401.26-25.09%
2020โ‚น535.63445.28%
2019โ‚น98.23-15.2%
2018โ‚น115.84-35.9%
2017โ‚น180.7169.57%
2016โ‚น106.57-27.67%
2015โ‚น147.3565.62%
2014โ‚น88.9611.63%
2013โ‚น79.7032.31%
2012โ‚น60.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.80-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น266.64-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น166.81-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น49.12-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น403.11-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel